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DTransannular patching is a valid alternative for tetralogy of Fallot and
complete atrioventricular septal defect repair
Gianluca Brancaccio, MD, PhD,a Guido Michielon, MD,a Sergio Filippelli, MD,a Gianluigi Perri, MD,a Duccio Di Carlo, MD,a
Fiore S. Iorio, MD,a Gianluca Oricchio, MD,a Roberta Iacobelli, MD,b Antonio Amodeo, MD,a and Roberto M. Di Donato, MDa
Objective:We report our experience with repair of tetralogy of Fallot associated with complete atrioventricular
septal defect, addressing in particular the need for a pulmonary valve in the right ventricular outflow tract.
Methods: Between 1992 and 2006, 33 children with tetralogy of Fallot and complete atrioventricular septal de-
fect were admitted; 26 had Down’s syndrome (79%). Thirty-two children had complete repair (18 primary, 14
staged); of the 15 who received initial palliation, 1 died before complete repair. Right ventricular outflow tract
obstruction was relieved by transannular patch in 14 cases (42%), infundibular patch with preservation of the
pulmonary valve in 7 (21%), and right ventricle–to–pulmonary artery conduit in 11 (33%).
Results: There were no hospital deaths. Actuarial survival was 96%  3.9% at 5 years and 85.9  1.1% at 10
years. Multivariate analysis showed that type of relief of right ventricular outflow tract obstruction did not influ-
ence survival (P ¼ .16), nor did the choice to use a valved conduit (P ¼ .82). Primary correction (P ¼ .05) and
lower weight at repair (P¼ .05) were associated with higher probability of survival. Mean follow-up was 69.3
5.9 months (range 0.2–282 months). There were 2 late deaths. Overall freedom from reoperation was 69% at 5
years and 38% at 10 years. Right ventricular outflow tract reconstruction without use of a valved conduit allowed
a significantly higher freedom from reinterventions (P< .05).
Conclusions: Tetralogy of Fallot associated with complete atrioventricular septal defect can be corrected at low
risk with favorable intermediate survival. Use of right ventricle–to–pulmonary artery conduit can be avoided in
two thirds of patients with no impact on survival, possibly improving overall freedom from reintervention.C
HThe association of tetralogy of Fallot (TOF) with complete
atrioventricular septal defect (CAVSD) is rare1,2; it was de-
tected in 5% of patients having CAVSD repair and in 1.7%
of patients having TOF repair.2-4 This anatomic complex ex-
hibits combined, though distinctive, morphologic features of
CAVSD and TOF.5 Initial experiences with surgical correc-
tion of this anomaly were affected by high mortality,4,6,7 but
technical advances have led to better outcomes.3,8 However,
the need for a valved reconstruction of the right ventricular
outflow tract (RVOT) still remains undefined. This report
shows the dispensability of a pulmonary valve in TOF-
CAVSD repair.
MATERIALS AND METHODS
Between 1992 and 2006, 33 consecutive children with CAVSD associ-
ated with TOF were referred to Bambino Gesu` Pediatric Hospital, Rome,
Italy. Excluded from this analysis were children with unbalanced CAVSDs
requiring univentricular repair and those with atrioventricular or ventricu-
loarterial discordance.
After parental consent was obtained, a retrospective review of all medical
records was carried out. Follow-up data were obtained from outpatient clinic
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assessed according to the New York Heart Association classification. The
study was approved by the local Ethics Committee.
Surgical Technique
Repair was accomplished by standard cardiopulmonary bypass with bi-
caval cannulation, mild to moderate hypothermia (28C–32C), and inter-
mittent infusion of antegrade blood cardioplegic solution. All preexisting
shunts were divided at initiation of cardiopulmonary bypass.
All children had closure of septal defects using the 2-patch technique.
The ventricular patch wasmade of glutaraldehyde-treated autologous or het-
erologous pericardium and was shaped like a comma. Closure of the ante-
rosuperior extension of the ventricular septal defect was facilitated by
exposure through a right infundibular incision. The cleft of the left atrioven-
tricular valve was closed with multiple interrupted monofilament sutures,
and competence of the valve was assessed by filling the left ventricle with
cold saline solution.
Closure of the ostium primum atrial septal defect followed repair of the
left atrioventricular valve and was also achieved by an autologous or heter-
ologous pericardial patch, always leaving the coronary sinus on the right
atrial side.
The RVOTwas explored from both the right atrium and the infundibular
incision. Resection of obstructive right ventricular muscle bundles was per-
formed. The pulmonary valve was sized by Hegar dilators. If the Z-score of
the pulmonary valve was2, the RVOT reconstruction was accomplished
by either transannular patch or valved conduit interposition according to the
surgeon’s preference. More recently, insertion of a polytetrafluoroethylene
(PTFE)monocusp valve was combined in cases of transannular patch recon-
struction.
Statistical Analysis
Statistical analysiswas conductedwith the SAS-Statview-1998 statistical
software, SAS Institute Inc (Cary, NC). Chi-square analysis was used to
compare discrete variables between the groups of children who had staged
repair and primary repair of CAVSD-TOF. Continuous variables, expressedardiovascular Surgery c Volume 137, Number 4 919
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DAbbreviations and Acronyms
CAVSD ¼ complete atrioventricular septal defect
PTFE ¼ polytetrafluoroethylene
RVOT ¼ right ventricular outflow tract
TOF ¼ tetralogy of Fallot
as means  standard deviations, were compared by unpaired t testing. One
patient (No. 11) died before complete correction and was excluded from the
analysis. Categorical analysis was conducted by chi-square and Fisher exact
test. Freedom from time-related events was conducted according to actuarial
and/or Kaplan-Meier technique; the resulting curves with 95% confidence
limits were compared with log-rank testing, and nomograms of the hazard
function were obtained. Selected and separate end points were defined as
death and reoperation. Early mortality was defined as death within 30
days from surgery or prior to hospital discharge. Variables associated
with an increased risk of death and reoperation were assessed by multivar-
iate logistic regression and Cox proportional risk analysis.
RESULTS
Preoperative Data
Among the 33 children admitted to our center, there were
17 boys and 16 girls, with a mean weight of 15.7 14.1 kg.
Twenty-six (79%) had Down’s syndrome, and 1 had Can-
trell syndrome. Cyanosis was present in 15 cases (48%).
A Rastelli type A CAVSD was diagnosed in 2 children,
and all other 31 patients had the classical type C variant.
Two patients had right aortic arch, 6 had persistent left supe-
rior vena cava to coronary sinus, and 1 hadWolff-Parkinson-
White syndrome.
Surgical Strategy
Primary repair was achieved in 18 patients at a mean age
of 32  28.3 months, whereas 15 patients (45%) had initial
palliation by systemic to pulmonary shunt (12), right ven-
tricular outflow patch (2), or percutaneous balloon dilatation
of the pulmonary valve (1). Mean age at palliation was 26.9
 33.5 months (range, 1.4–103.7 months). One patient died
suddenly at home after systemic-to-pulmonary shunt, prior
to complete repair. The remaining 14 patients had secondary
complete repair at a mean of 55.1  58.3 months (range,
1.2–210.7 months) after palliation.
Hospital Outcome
On the whole, 32 children had complete repair at a mean
age of 54.9 53.9 months (range, 4.6–224.4 months). There
were no early deaths. Table 1 compares the preoperative and
operative data between primary and staged repair.
Early reoperation was necessary in 6 patients including
mediastinal reexploration for bleeding in 2 patients, dia-
phragm plication in 1, and implantation of a pacemaker for
complete heart block in 3 patients (9%; Nos. 10, 12, and
15; Table 2). Patient No. 28 had urgent reoperation for severe
aortic insufficiency on postoperative day 5. The noncoronary920 The Journal of Thoracic and Cardiovascular Surcusp of the aortic valve was torn and had successful repair by
autologous pericardial patch; the aortic valve function of this
patient remains normal 2 years postoperatively.
Follow-up
Follow-upassessmentwas available for 31patientswhohad
complete correction (97%). The mean follow-up was 69.3
5.9 months (range, 0.2–282months). During this period, there
were 2 deaths. Patient No. 4 (Table 2) died 20 days after reop-
eration for residual ventricular septal defect and pulmonary
stenosis with dilatation of RVOT. His postoperative course
was complicated by mediastinitis and multiple organ failure.
The other patient died at homewhile awaiting conduit replace-
ment (patient No. 1). Both children hadDown’s syndrome and
both had staged repair of TOF-CAVSD.
Actuarial survival was 96%  3.9% at 5 years and
85.9%  1.1% at 10 years (Figure 1). Among the 29 survi-
vors, 55% were in class I, 38% in class II, 5% in class III,
and 2% in class IV.
Role of RVOT Reconstruction
Right ventricular outflow tract obstruction was relieved
by a transannular patch in 14 cases (42%), with a PTFE
monocusp in 4 cases, by an infundibular patch with preser-
vation of the pulmonary valve in 7 cases (21%), and a right
ventricle–to–pulmonary artery valved conduit interposition
was used in 11 cases (33%). The type of relief of RVOT
did not influence survival (P¼ .16). Use of a prosthetic con-
duit (P ¼ .82) did not affect surgical outcome (Figure 2).
Staged repair (P¼ .05) and higher weight (P¼ .05) at cor-
rection were possibly associated with an increased probabil-
ity of death (Table 3).
Complications and Reoperations
Eight patients (25%) required late reoperations for con-
duit replacement (3), closure of residual ventricular septal
TABLE 1. Comparison of children having primary and staged repair
Variable
Staged
repair
Primary
repair P
Patients (n) 15 18 .856
Preoperative
Age (mo) 81.4  66.1 32  28.3 .655
Weight (kg) 22.2  19.5 11.1  5.5 .055
Sex (M/F) 8/7 9/9 .745
Down’s syndrome (n) 15 11 .078
Operative
ECC (min) 331  109.6 297.5  77.5 .543
XCL (min) 174.8  44.7 180  55.3 .944
Transannular patching (n) 5 9 .083
Valved conduit (n) 5 6 .123
Infundibular patching (n) 4 3 .345
ICU stay (d) 7  6.5 6.1  5.8 .566
ECC, Extracorporeal circulation; XCL, aortic crossclamping time; BT, Blalock-
Taussig; RVOT, right ventricular outflow tract; ICU, intensive care unit.gery c April 2009
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DTABLE 2. Clinical features and follow-up data on 33 patients with AVSD and TOF
Patient No. Sex Weight (kg)* Genetic syndrome Palliation Correction (RVOT) Follow-up
1 F 14 Down’s syndrome BT shunt Valved conduit Death
2 M 11 Down’s syndrome — Transannular patch Alive
3 F 9.7 Down’s syndrome — Valved conduit Alive
4 M 83 Down’s syndrome BT shunt Infundibular patch Death
5 M 4 Down’s syndrome — Transannular patch Alive
6 F 20 Down’s syndrome BT shunt Infundibular patch Alive
7 F 16 Down’s syndrome — Transannular patch Alive
8 F 3.5 — — Transannular patch Alive
9 M 6 Down’s syndrome — Infundibular patch Alive
10 M 5.1 Down’s syndrome — Infundibular patch Alive
11 F — Down’s syndrome BT shunt — Death before repair
12 F 30 Down’s syndrome BT shunt Valved conduit Alive
13 M 20 Down’s syndrome Perc. Dilat. Transannular patch Alive
14 M 20 Down’s syndrome — Infundibular patch Alive
15 M 9.1 Down’s syndrome — Transannular patch Alive
16 M 24 Down’s syndrome BT shunt Transannular patch Alive
17 M 15 Down’s syndrome — Valved conduit Alive
18 F 13 Down’s syndrome RVOFP Valved conduit Alive
19 M 12 Down’s syndrome BT shunt Infundibular patch Alive
20 F 7.4 Cantrell syndrome — Valved conduit Alive
21 M 9.7 Down’s syndrome BT shunt Infundibular patch Alive
22 M 11.6 Down’s syndrome BT shunt Transannular patch Alive
23 F 10 — — Transannular patch Alive
24 M 19.3 — — Transannular patch Alive
25 M 22 Down’s syndrome BT shunt Valved conduit Alive
26 F 28 Down’s syndrome BT shunt Transannular patch Alive
27 F 16 — — Transannular patch Alive
28 F 8.5 — — Transannular patch Alive
29 F 8.8 Down’s syndrome BT shunt Transannular patch Alive
30 F 12 Down’s syndrome — Valved conduit Alive
31 F 20 — — Valved conduit Alive
32 M 15 Down’s syndrome RVOFP Valved conduit Alive
33 M 6.6 Down’s syndrome — Valved conduit Alive
AVSD, Atrioventricular septal defect; TOF, tetralogy of Fallot; BT, Blalock-Taussig shunt; Perc. Dilat., perctaneous dilatation; RVOFP, right ventricular outflow patch. *Weight at
correction.defect (3), mitral valve replacement (1), and tricuspid valve
replacement (1). Overall freedom from reoperation after
complete repair was 69% at 5 years and 38% at 10 years.
Freedom from reoperations after complete repair was 29%
after 6 years in the staged repair group and 50.4% at 10 years
in the primary repair group (P ¼ .11; Figure 3). Differences
between the 2 groups were evident, although not statistically
significant, probably due to the small size of the cohort.
Freedom from reinterventions at 10 years was 62.2% 
20% in the no-conduit group compared with 14.0% 
12.9% in the conduit group (P ¼ .05; Figure 4). Presence
of trisomy 21was an inverse risk factor for reintervention ac-
cording to Cox proportional hazard (P ¼ .008; Table 4).
DISCUSSION
Tetralogy of fallot associated with CAVSD is an uncom-
mon finding.1,2 The current literature reports few studieswith
small cohorts.3,5,8-11 To our knowledge, our experience rep-
resents one of the largest cohorts with long-term follow-up.The Journal of Thoracic andThe association of TOF and CAVSDwas long considered
a surgical challenge.5,8-11 Mortality rate at correction ranged
between 15% and 33%.10,12,13 Recent reports confirm
FIGURE 1. Overall actuarial survival after complete repair of tetralogy of
Fallot with complete atrioventricular septal defect.Cardiovascular Surgery c Volume 137, Number 4 921
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Da reduction in mortality and morbidity after surgical correc-
tion.3,5,8 These improvements can be attributed to several
factors, including better diagnostic accuracy, perioperative
care, and surgical approach.
Our study shows the following:
1. There was no hospital mortality at repair, and the actuar-
ial survival was 86% at 10 years. These findings demon-
strate that this anomaly can be corrected with low risk and
favorable intermediate survival. Therefore, our data con-
firm the recent improvements in surgical repair of this
complex lesion.3,5,8,12,13
2. The type of RVOT obstruction relief did not affect surgi-
cal outcome. This finding is in contrast with previous rec-
ommendations about the mandatory use of a valved
conduit to avoid pulmonary regurgitation particularly in
the critical early postoperative period.10 We suggest
that in case of favorable anatomy (normal pulmonary ar-
tery size, good right ventricular function), the RVOT ob-
struction can be effectively relieved by transannular or
TABLE 3. Forward stepwise Cox proportional hazard model for
mortality
Variable Chi-square DF P
Female sex 0.186 1 .6660
Age at repair 3.017 1 .0824
Type of repair 0.850 2 .6539
Conduit 0.118 1 .7311
Non-Down’s syndrome 0.268 1 .6048
Staged repair 3.571 1 .0588
Weight at repair 3.826 1 .0505
ECC 0.165 1 .6850
XCL 1.287 1 .2566
DF, Degree of freedom; ECC, extracorporeal circulation; XCL, aortic crossclamping
time.
FIGURE 2. Kaplan-Meier survival probability according to type of right
ventricular outflow tract repair. RV-PA, Right ventricle to pulmonary artery.922 The Journal of Thoracic and Cardiovascular Sulimited infundibular patching. In our experience, avoid-
ance of right ventricle–to–pulmonary artery conduit
was associated with a significantly higher freedom from
reintervention. Our current policy includes the construc-
tion of a PTFE monocusp valve to reduce early pulmo-
nary regurgitation, yet realizing the short-term efficacy
of this approach.14,15
3. Primary repair possibly improves long-term survival.
This finding is in accordance with the results described
by Najm et al,3 who concluded that primary repair is su-
perior to staged repair. Previous recommendations for
FIGURE 3. Kaplan-Meier freedom from reoperation in primary versus
staged repair of tetralogy of Fallot with complete atrioventricular septal
defect.
FIGURE 4. Kaplan-Meier freedom from reoperations in conduit and no-
conduit group.rgery c April 2009
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Dage at repair have been in the range of 4 to 6 years2,4,16;
palliation was endorsed in severely cyanotic infants to
carry them through that age target. Our results show
that repair at 2 years of age allows excellent outcome.
Since 2000, our policy favors primary repair to avoid po-
tential complications (eg, prolonged cyanosis, progres-
sive ventricular hypertrophy, prolonged left ventricular
volume overload, interstage mortality, and increasing
atrioventricular valve regurgitation).
4. Presence of genetic syndrome was common in our cohort
(80%). This finding confirms the recent knowledge about
the relationship between trisomy 21 and congenital heart
defects.17,18 However, in contrast to the experience of
Karl8 and Uretzky and colleagues,4 trisomy 21 was not
found to be a risk factor for death. Rather, Down’s syn-
drome appeared a protective factor for freedom from re-
intervention.
This retrospective study has at least 2 limitations. First, it
reports an experience across 15 years, during which impor-
tant improvements in pre- and postoperative care have been
achieved. Second, the small number of patients in some sub-
groups suggests a careful interpretation of data analysis and
requires further confirmation.
CONCLUSION
Teratology of fallot-CAVSD can be corrected at low risk
and good intermediate survival. Our results demonstrate that
systematic use of right ventricle–to–pulmonary artery con-
TABLE 4. Forward stepwise Cox proportional hazard model for
reoperations
Variable Chi-square DF P
XCL 0.007 1 .9317
ECC 0.141 1 .7077
Weight at repair 0.243 1 .6220
Primary repair 2.272 1 .1318
Male sex 3.462 1 .0628
Age at repair 0.366 1 .5449
Repair with RV-PA conduit 3.291 1 .0697
Non-Down’s syndrome 7.046 1 .0079
Type of repair 3.404 2 .1823
DF, Degree of freedom; ECC, extracorporeal circulation; XCL, aortic crossclamping
time; RV-PA, right ventricle–to–pulmonary artery.The Journal of Thoracic and Cduit can be avoided at least in cases of favorable anatomy.
Transannular patching is a valid alternative for RVOT re-
construction and prevents multiple conduit replacement.
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